- JP-listed companies
- Vitabrid Japan Inc.
- Financials
- Proceeds from issuance of term debt, net
Vitabrid Japan Inc. (542A)
Market cap
¥5.6B
P/E ratio
7.6x
Vitabrid Japan makes health and beauty supplements sold directly to consumers online, with their sugar and fat-blocking supplement Terminalia First driving most sales.
| Period End | Proceeds from issuance of term debt, net (Million JPY) | YoY (%) |
|---|---|---|
| Feb 28, 2025 | 200 |